HF006
The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 105 | 106 | 99.1% | |
| HF004 | 2020 | 92 | 96 | 95.8% | |
| HF006 | 2021 | 105 | 113 | 92.9% | |
| HF006 | 2022 | 103 | 106 | 97.2% | |
| HF006 | 2023 | 114 | 116 | 98.3% |
